NASDAQ:NRXP
NRx Pharmaceuticals, Inc. Stock News
$2.82
+0.0100 (+0.356%)
At Close: May 08, 2024
Company to Present Corporate and Psychiatry Franchise Update During Webcast, June 27, 2022, at 7:00am ET RADNOR, Pa. , June 23, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), ("NRx
Why Is NRx Pharmaceuticals (NRXP) Stock Down 60% Today?
02:26pm, Thursday, 26'th May 2022
Today, investors in NRx Pharmaceuticals and NRXP stock have seen heavy selling pressure as a key trial was stopped due to futility. The post Why Is NRx Pharmaceuticals (NRXP) Stock Down 60% Today?
Why NRX Pharmaceuticals Shares Are Trading Lower During Premarket On Thursday?
07:54am, Thursday, 26'th May 2022
Based on the review of approximately 460 patients, Data Safety and Monitoring Board (DSMB) determined that the evaluation of NRx Pharmaceuticals Inc's (NASDAQ: NRXP) Zyesami (aviptadil) should ceas
NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. Global Investment Conference
07:20am, Thursday, 19'th May 2022
Company to Present Corporate Update During Investor Webcast, May 24, 2022, at 7:00am ET RADNOR, Pa. , May 19, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmac
NRx Pharmaceuticals, Inc. (NRXP) CEO Robert Besthof on Q1 2022 Results - Earnings Call Transcript
11:05am, Monday, 16'th May 2022
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP ) Q1 2022 Earnings Conference Call May 16, 2022 8:30 AM ET Company Participants Robert Besthof – Interim Chief Executive Officer, Head of Operations & Chief Co
NRx Pharmaceuticals to Report First Quarter 2022 Results on May 16, 2022
08:11am, Tuesday, 10'th May 2022
--Company to Host Conference Call May 16, 2022, at 8:30AM ET-- RADNOR, Pa. , May 10, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"), a clinical-stage, biopharmac
NRx Pharmaceuticals' Interim CEO and other Leaders to Present at 21st Annual Needham Virtual Healthcare Conference
08:57am, Friday, 08'th Apr 2022
Company to Present Corporate Update During Investor Webcast, April 14, 2022, at 4:30pm ET RADNOR, Pa. , April 8, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"),
NRx Pharmaceuticals, Inc. (NRXP) CEO Robert Besthof on Q4 2021 Results - Earnings Call Transcript
05:19pm, Thursday, 31'st Mar 2022
NRx Pharmaceuticals, Inc. (NRXP) CEO Robert Besthof on Q4 2021 Results - Earnings Call Transcript
NRx Pharma Says I-SPY Study Of Inhaled Zyesami In Critical COVID-19 Stopped
01:33pm, Thursday, 31'st Mar 2022
Quantum Leap Healthcare Collaborative (QLHC) announced that the nebulized form of NRx Pharmaceuticals Inc's (NASDAQ: NRXP) Zyesami (Aviptadil) in the I-SPY COVID Trial of critical patients had been
NRx Pharmaceuticals to Report Year-End 2021 Results on March 31, 2022
10:15am, Monday, 28'th Mar 2022
--Company to Host Conference Call March 31, 2022, at 8:30AM ET--- RADNOR, Pa. , March 28, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"), a clinical-stage, biop
NRx Pharmaceuticals: Potential For First In Bipolar Depression Suicidal Ideation Treatment, Along As Covid-19 Play
10:37am, Wednesday, 23'rd Feb 2022
NRx Pharmaceuticals: Potential For First In Bipolar Depression Suicidal Ideation Treatment, Along As Covid-19 Play
NRx Pharmaceuticals Raises $25M Via Equity To Support Its Pipeline Development
11:22am, Monday, 31'st Jan 2022
NRx Pharmaceuticals NRXP has announced the private placement of 7.8 million shares priced at a premium to market under Nasdaq rule, for gross proceeds of $25 million. [ALERT] Nic Chahine shares his
NRx Pharma's Zyesami Access Expanded To COVID-19 Patients Who Exhausted All Approved Treatments
08:50am, Tuesday, 18'th Jan 2022
NRx Pharmaceuticals (NASDAQ: NRXP) has announced enhancements to its Expanded Access and Right to Try programs. The programs enable patients to receive Zyesami (aviptadil) upon a physician's presc
NRx Pharma Files Counterclaim Against Relief Therapeutics Over COVID-19 Candidate Rights
07:18am, Thursday, 13'th Jan 2022
NRx Pharmaceuticals Inc (NASDAQ: NRXP) has filed a counterclaim against its former partner, Relief Therapeutics Holdings (OTC: RLFTF), in an ongoing dispute over the COVID-19 treatment Zyesami (a
3 Reddit Penny Stocks For Your Watch List In January 2022
03:33pm, Monday, 10'th Jan 2022
Reddit penny stocks to watch this week. The post 3 Reddit Penny Stocks For Your Watch List In January 2022 appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
